CLOs on the Move

Repertoire

www.repertoire.com

 
Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Andrea DiFabio
Executive Vice President and Chief Legal Officer Profile
Andrea DiFabio
Executive Vice President, Chief Legal Officer and Administrative Officer Profile

Similar Companies

Foodsmart

With the largest national network of registered dietitians, weve helped over 1.5 million members improve their health with personalized nutrition guidance from the comfort of their own home.

Clinical Trials of Texas

Clinical Trials of Texas is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AristaMD

AristaMD develops solutions to improve patient outcomes through efficiency in healthcare.

Berg LLC

BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.

aClaim

aClaim is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.